Jared Kelly, CEO of Oncolytics Biotech ONCY, has filed 3 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $34.3K. The latest trade was on 06/01.

JK

JK

Jared Kelly

CEO

Company

Oncolytics Biotech ONCY

First filing

26/02/13

Trades

4 trades

Buys / sales

3 / 0

12-month net buying

$34.3K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Oncolytics BiotechONCY	Open-market buy	03/12	03/13	5,050 sh	$0.96	$4,848	+4.6%
Oncolytics BiotechONCY	Open-market buy	02/11–02/12	02/13	35,100 sh2 trades	$0.84avg.	$29,484	+47.5%